A case of Tuberculosis in the Patient after Orthotopic Heart Transplantation
https://doi.org/10.21292/2075-1230-2021-99-9-46-52
Abstract
The article presents a clinical case of tuberculosis during the drug-induced immunosuppression after orthotopic heart transplantation. The anti-tuberculosis therapy in combination with immunosuppressive drugs is described. The course of tuberculosis in the patient was characterized by rapid changes of clinical and radiological signs, both negative and positive with the administration of adequate chemotherapy. The clinical management of this patient required skills of emergency care for life-threatening conditions and command of procedures aimed to prevent their development.
About the Authors
T. V. Pyanzova
Kemerovo State Medical University
Russian Federation
Russian Federation
Tatiana V. Pyanzova, Candidate of Medical Sciences, Associate Professor, Head of Phthisiology Department
22A, Voroshilova St., Kemerovo, 650029.
6, Sosnovy Rd, Kemerovo, 650002.
Phone: 384-2-54-56-51; 384-2-64-06-05.
E. R. Basters
Kemerovo State Medical University
Russian Federation
Russian Federation
Elza R. Basters, Resident of Phthisiology Department
22A, Voroshilova St., Kemerovo, 650029.
6, Sosnovy Rd, Kemerovo, 650002.
Phone: 384-2-54-56-51; 384-2-64-06-05.
T. N. Zvereva
Kemerovo State Medical University
Russian Federation
Russian Federation
Tatiana N. Zvereva, Candidate of Medical Sciences, Associate Professor of Cardiology and Cardiovascular Surgery Department
22A, Voroshilova St., Kemerovo, 650029.
6, Sosnovy Rd, Kemerovo, 650002.
Phone: 384-2-54-56-51; 384-2-64-06-05.
N. M. Galayda
Kemerovo Regional Clinical
Phthisiopulmonary Medical Center
Russian Federation
Russian Federation
Nina M. Galayda, Head of Pulmonary Tuberculosis Therapy Department no. 4
5, Khimikov Ave., Kemerovo, 650036.
Phone: 384-2-54-45-40
E. A. Grigorieva
Kemerovo State Medical University
Russian Federation
Russian Federation
Elena A. Grigorieva, Candidate of Medical Sciences, Assistant of Phthisiology Department
22A, Voroshilova St., Kemerovo, 650029.
6, Sosnovy Rd, Kemerovo, 650002.
Phone: 384-2-54-56-51; 384-2-64-06-05.
References
1. Аksenova V.А., Baryshnikova L.А., Klevno N.I., Kudlay D.А. Screening of children and adolescents for tuberculosis infection in Russia - past, present, future. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 9, pp. 59-67. (In Russ.)
2. Borisov S.E., Lukina G.V., Slogotskaya L.V., Kochetkov Ya.А., Guntupova L.D., Kulikovskaya N.V. Screening and monitoring of tuberculous infection in rheumatologic patients, treated by genetically engineered biological agents. Tuberculosis and Lung Diseases, 2011, vol. 88, no. 6, pp. 42-50. (In Russ.)
3. Gordeeva O.M., Karpina N.L., Larionova E.E., Аndrievskaya I.Yu., Kiseleva E.А., Lovacheva O.V. Aspects of pulmonary tuberculosis verification in those at the terminal stage of chronic kidney disease. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 5, pp. 14-21. (In Russ.) Doi 10.21292/2075-1230-2018-96-5-14-20.
4. Gotye S.V., Khomyakov S.M. Donorship and organ transplantation in the Russian Federation in 2018. The 11th report of the Register by the Russian Transplantation Society. Vestnik Transplantologii I Iskusstvennykh Organov, vol. 21, no. 3, pp. 7-32. (In Russ.) doi: 10.15825/1995-1191-2019-3-7-32.
5. Kudlay D.А. Biomarkers and immunological tests. Experimental and clinical parallels of latent tuberculosis infection. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 8, pp. 63-74. (In Russ.) http://doi.org/10.21292/2075-1230-2020-98-8-63-74.
6. Kudlay D.А., Starshinova А.А., Dovgalyuk I.F. Tuberculous recombinant allergen: 10-year experience of using this test in children and adolescents in the Russian Federation (data of meta analysis). Pediatriya Im. G.N. Speranskogo, 2020, vol. 99, no. 3, pp. 121-129. (In Russ.)
7. National clinical guidelines on cardiac transplantation and mechanical circulatory support. (Approved by the Russian Ministry of Health). Epub. (In Russ.). 2016. Available: https://legalacts.ru/doc/natsionalnye-klinicheskie-rekomendatsii-transplantatsija-serdtsa-i-mekhanicheskaja-podderzhka-krovoobrashchenija/ (Accessed 07.06.2020).
8. Slogotskaya L.V., Sinitsyn M.V., Kudlay D.А. Possibilities of immunological tests in the diagnosis of latent tuberculosis infection and tuberculosis. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 11, pp. 46-59. (In Russ.)
9. Aguado J.M., Torre-Cisneros J., Fortún J. et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin. Infect. Dis., 2009, vol. 48, no. 9, pp. 1276-1284. doi: 10.1086/597590.
10. Aspler A., Long R., Trajman A. et al. Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB. Thorax, 2010, vol. 65, no. 7, pp. 582-587. DOI:10.1136/thx.2009.125054.
11. Harari A., Rozot V., Enders F.B. et al. Dominant TNF-[alpha]+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nature Med., 2011, vol. 17, no. 3, pp. 372-376.
12. Mack U., Migliori G.B., Sester M. et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J., 2009, vol. 33, no. 5, pp. 956-973. DOI:10.1183/09031936.00120908.
13. Santoro-Lopes G., Subramanian A.K., Molina I. et al. Tuberculosis recommendations for solid organ transplant recipients and donors. Transplantation, 2018, vol. 102, 2S suppl. 2. pp. 102S60‐S65. doi:10.1097/TP.0000000000002014.
14. Sester M., van Leth F., Bruchfeld J. et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am. J. Respir. Crit. Care Med., 2014, vol. 190, no. 10, pp. 1168-1176. doi:10.1164/rccm.201405-0967OC.
15. Shovkun L., Aksenova V., Kudlay D., et al. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA). Eur. Respir. J., 2018, vol. 52, no. S62, PA2733. doi: 10.1183/13993003.congress-2018.PA2733.
16. Singh N., Paterson D.L. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin. Infect. Dis., 1998, vol. 27, no. 5, pp. 1266-1277. doi:10.1086/514993.
17. Sun H.Y. Treating tuberculosis in solid organ transplant recipients. Curr. Opin. Infect. Dis., 2014, vol. 27, no. 6, pp. 501-505. DOI:10.1097/QCO.0000000000000102.
18. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment, 2020. Epub.. Available: https://www.who.int/publications/i/item/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment (Accessed 07.06.2020).
Review
For citations:
Pyanzova T.V., Basters E.R., Zvereva T.N., Galayda N.M., Grigorieva E.A. A case of Tuberculosis in the Patient after Orthotopic Heart Transplantation. Tuberculosis and Lung Diseases. 2021;99(9):46-52. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-9-46-52
Views:
662
Email this article 